ShuYu Civilian Pharmacy Corp., Ltd.

SZSE:301017 Lagerbericht

Marktkapitalisierung: CN¥5.5b

ShuYu Civilian Pharmacy Vergangene Ertragsentwicklung

Vergangenheit Kriterienprüfungen 0/6

ShuYu Civilian Pharmacy's earnings have been declining at an average annual rate of -15.6%, while the Consumer Retailing industry saw earnings growing at 3.5% annually. Revenues have been growing at an average rate of 22.2% per year.

Wichtige Informationen

-15.6%

Wachstumsrate der Gewinne

-10.1%

EPS-Wachstumsrate

Consumer Retailing Wachstum der Industrie12.8%
Wachstumsrate der Einnahmen22.2%
Eigenkapitalrendite-2.1%
Netto-Marge-0.4%
Letzte Ertragsaktualisierung30 Sep 2024

Jüngste Aktualisierungen vergangener Leistungen

Recent updates

ShuYu Civilian Pharmacy (SZSE:301017) Seems To Be Using A Lot Of Debt

Oct 03
ShuYu Civilian Pharmacy (SZSE:301017) Seems To Be Using A Lot Of Debt

A Piece Of The Puzzle Missing From ShuYu Civilian Pharmacy Corp., Ltd.'s (SZSE:301017) 25% Share Price Climb

Sep 06
A Piece Of The Puzzle Missing From ShuYu Civilian Pharmacy Corp., Ltd.'s (SZSE:301017) 25% Share Price Climb

ShuYu Civilian Pharmacy (SZSE:301017) Could Be Struggling To Allocate Capital

Jul 25
ShuYu Civilian Pharmacy (SZSE:301017) Could Be Struggling To Allocate Capital

ShuYu Civilian Pharmacy Corp., Ltd. (SZSE:301017) Shares May Have Slumped 32% But Getting In Cheap Is Still Unlikely

Jun 21
ShuYu Civilian Pharmacy Corp., Ltd. (SZSE:301017) Shares May Have Slumped 32% But Getting In Cheap Is Still Unlikely

ShuYu Civilian Pharmacy (SZSE:301017) Use Of Debt Could Be Considered Risky

Jun 20
ShuYu Civilian Pharmacy (SZSE:301017) Use Of Debt Could Be Considered Risky

These 4 Measures Indicate That ShuYu Civilian Pharmacy (SZSE:301017) Is Using Debt Extensively

Mar 04
These 4 Measures Indicate That ShuYu Civilian Pharmacy (SZSE:301017) Is Using Debt Extensively

Aufschlüsselung der Einnahmen und Ausgaben

Wie ShuYu Civilian Pharmacy Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.


Gewinn- und Umsatzhistorie

SZSE:301017 Einnahmen, Ausgaben und Erträge (CNY Millions)
DatumEinnahmenUmsatzAllgemeine und VerwaltungskostenF&E-Ausgaben
30 Sep 249,735-422,4430
30 Jun 249,748182,4200
31 Mar 249,558792,3970
31 Dec 239,1911332,2820
30 Sep 239,1102612,1820
30 Jun 238,6942572,0580
31 Mar 238,3082441,9190
01 Jan 237,8232291,8320
30 Sep 226,8541351,6570
30 Jun 226,2321391,5580
31 Mar 225,7241271,4560
01 Jan 225,3221151,3290
30 Sep 215,0182031,1550
30 Jun 214,8712331,0640
31 Mar 214,7052411,0600
31 Dec 204,6402161,0330
31 Dec 193,4671119540
31 Dec 182,8881138320

Qualität der Erträge: 301017 is currently unprofitable.

Wachsende Gewinnspanne: 301017 is currently unprofitable.


Analyse von freiem Cashflow und Gewinn


Analyse des Gewinnwachstums in der Vergangenheit

Ergebnisentwicklung: 301017 is unprofitable, and losses have increased over the past 5 years at a rate of 15.6% per year.

Beschleunigtes Wachstum: Unable to compare 301017's earnings growth over the past year to its 5-year average as it is currently unprofitable

Erträge im Vergleich zur Industrie: 301017 is unprofitable, making it difficult to compare its past year earnings growth to the Consumer Retailing industry (6%).


Eigenkapitalrendite

Hohe Eigenkapitalrendite: 301017 has a negative Return on Equity (-2.09%), as it is currently unprofitable.


Kapitalrendite


Rendite auf das eingesetzte Kapital


Entdecken Sie starke Unternehmen, die in der Vergangenheit erfolgreich waren